Page last updated: 2024-10-29

indirubin-3'-monoxime and Osteoporosis

indirubin-3'-monoxime has been researched along with Osteoporosis in 1 studies

indirubin-3'-monoxime: has antiangiogenic activity
indirubin-3'-monoxime : A member of the class of biindoles that is indirubin in which the keto group at position 3' has undergone condensation with hydroxylamine to form the corresponding oxime.

Osteoporosis: Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.

Research Excerpts

ExcerptRelevanceReference
"Osteoporosis is a major global health issue in elderly people."1.40Indirubin-3'-oxime reverses bone loss in ovariectomized and hindlimb-unloaded mice via activation of the Wnt/β-catenin signaling. ( Cha, PH; Choi, KY; Min, do S; Zahoor, M, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zahoor, M1
Cha, PH1
Min, do S1
Choi, KY1

Other Studies

1 other study available for indirubin-3'-monoxime and Osteoporosis

ArticleYear
Indirubin-3'-oxime reverses bone loss in ovariectomized and hindlimb-unloaded mice via activation of the Wnt/β-catenin signaling.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2014, Volume: 29, Issue:5

    Topics: Animals; beta Catenin; Bone Density; Female; HEK293 Cells; Hindlimb Suspension; Humans; Indoles; Mic

2014